Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
This study was submitted for evaluation by the Ethics Committee on the Use of Animals (CEUA) of UNESC under protocol number 07/2023
It means the safety profile is unknown rather than established
In the SUSTAIN trial, 52% of patients receiving semaglutide experienc ed gastrointestinal side effects, compared with 35% in the placebo group
2.2 Study Selection Trials were deemed eligible for inclusion if they 1) were RCT design
US$ 23.34
US$ 25.45
US$ 28.34
US$ 29.58
US$ 21.03
US$ 24.21
:max_bytes(150000):strip_icc()/Health-GettyImages-PharmacistsGLP1s-091528aad5314e0f94e92880dee97289.jpg)
